A novel AKR1C3 specific prodrug TH3424 with potent anti-tumor activity in liver cancer
Excerpt:
TH3424 showed specific killing of liver cancer cells with AKR1C3 overexpression both in vitro and in vivo…TH3424 is a promising drug candidate for liver cancer and other types of cancers overexpressing AKR1C3.